{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03850574",
            "orgStudyIdInfo": {
                "id": "HM-FLTI-101"
            },
            "organization": {
                "fullName": "Aptose Biosciences Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
            "officialTitle": "A Phase 1/2 Open Label, Multicenter, Dose Escalation and Expansion Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)",
            "acronym": "APTIVATE",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "clinical-trial-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-tuspetinib-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-03-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-01-28",
            "studyFirstSubmitQcDate": "2019-02-20",
            "studyFirstPostDateStruct": {
                "date": "2019-02-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-05",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Aptose Biosciences Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tuspetinib (HM43239) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)",
            "detailedDescription": "This is a Phase 1/2, open-label, multi-center study to assess the efficacy, safety, tolerability, pharmacokinetics, including recommended phase 2 dose (RP2D) of tuspetinib (HM43239) monotherapy in subjects with relapsed or treatment-refractory acute myeloid leukemia (AML). This study will also evaluate the safety, tolerability, and PK parameters of tuspetinib (HM43239) in combination with venetoclax when administered in patients with R/R AML"
        },
        "conditionsModule": {
            "conditions": [
                "Relapsed or Refractory Acute Myeloid Leukemia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "Three parts in the study - Part A (dose escalation, tuspetinib as a single agent), Part B (dose exploration, tuspetinib as a single agent), Part C (dose expansion, tuspetinib as a single agent and combo arm of tuspetinib with venetoclax)",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 218,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part A Dose Escalation",
                    "type": "EXPERIMENTAL",
                    "description": "For Part A (tuspetinib as a single agent), dose escalation cohort is planned up to 6 dose levels. If a subject in the dose escalation cohort at any dose level achieves clinical response then the dose level will continue to enroll in Part B. If one DLT or less is observed in the 6 patients (\\<1/6 DLT observed) in Part A, up to 20 evaluable patients can be enrolled in Part B at that dose level.",
                    "interventionNames": [
                        "Drug: Tuspetinib"
                    ]
                },
                {
                    "label": "Part B Dose Exploration",
                    "type": "EXPERIMENTAL",
                    "description": "For Part B (tuspetinib as a single agent), dose exploration cohort is planned up to 4 dose levels.",
                    "interventionNames": [
                        "Drug: Tuspetinib"
                    ]
                },
                {
                    "label": "Part C Dose Expansion (tuspetinib as a single agent)",
                    "type": "EXPERIMENTAL",
                    "description": "Part C, dose expansion, consists of 2 arms (tuspetinib as a single agent or tuspetinib plus venetoclax). Patients will be randomly assigned to either arm based on the number of slots available. The initial tuspetinib dose for the single arm will be 120mg.",
                    "interventionNames": [
                        "Drug: Tuspetinib"
                    ]
                },
                {
                    "label": "Part C Dose Expansion (Combination Arm - tuspetinib and venetoclax)",
                    "type": "EXPERIMENTAL",
                    "description": "Part C, dose expansion, consists of 2 arms (tuspetinib or tuspetinib plus venetoclax). Patients will be randomly assigned to either arm based on the number of slots available. The initial tuspetinib dose for the combo arm will be 80mg.",
                    "interventionNames": [
                        "Drug: Tuspetinib",
                        "Drug: Venetoclax Oral Tablet"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Tuspetinib",
                    "description": "Daily (QD), continuous dosing",
                    "armGroupLabels": [
                        "Part A Dose Escalation",
                        "Part B Dose Exploration",
                        "Part C Dose Expansion (Combination Arm - tuspetinib and venetoclax)",
                        "Part C Dose Expansion (tuspetinib as a single agent)"
                    ],
                    "otherNames": [
                        "HM43239"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Venetoclax Oral Tablet",
                    "description": "Venetoclax will be given to patients in combo treatment group (Part C) either in 50 mg or 100 mg tablets",
                    "armGroupLabels": [
                        "Part C Dose Expansion (Combination Arm - tuspetinib and venetoclax)"
                    ],
                    "otherNames": [
                        "Venetoclax"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Recommended Phase 2 dose",
                    "description": "To determine the recommended phase 2 dose based on safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) consideration",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Safety of HM43239",
                    "description": "Determine the maximum tolerated dose at which no more than 1 out of 6 patients experience a dose-limiting toxicity or establish the safety of clinically effective dose below the MTD if the MTD is not reached.relapsed or treatment-refractory (R/R) AML",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Tolerability of HM43239",
                    "description": "To determine the frequency and severity of drug-related adverse events across different dose levels when administered in patients with R/R AML",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Safety of HM43239 in combination with venetoclax",
                    "description": "Determine the maximum tolerated dose of HM43239 in combination with venetoclax at which no more than 1 out of 6 patients experience a dose-limiting toxicity or establish the safety of clinically effective dose below the MTD if the MTD is not reached.relapsed or treatment-refractory (R/R) AML",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Tolerability of HM43239 in combination with venetoclax",
                    "description": "To determine the frequency and severity of drug-related adverse events across different dose levels of HM43239 in combination with venetoclax when administered in patients with R/R AML",
                    "timeFrame": "4 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Anti-leukemic activity of HM43239",
                    "description": "To investigate the rate of complete remission (CR), CR with partial hematologic recovery (CRh), CR with incomplete platelet recovery (CRp), CR with incomplete hematologic recovery (CRi), and partial remission (PR) of patients taking HM43239",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Anti-leukemic activity of HM43239 in combination with venetoclax",
                    "description": "To investigate the rate of complete remission (CR), CR with partial hematologic recovery (CRh), CR with incomplete platelet recovery (CRp), CR with incomplete hematologic recovery (CRi), and partial remission (PR) of patients taking HM43239 in combination with venetoclax",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Pharmacokinetic variables including maximum plasma concentration (Cmax)",
                    "description": "Pharmacokinetic variables including maximum plasma concentration (Cmax)",
                    "timeFrame": "Cycle 1 (at least 28 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including minimum plasma concentration (Cmin)",
                    "description": "Pharmacokinetic variables including minimum plasma concentration (Cmin)",
                    "timeFrame": "Cycle 1 (at least 28 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including area under the curve (AUC)",
                    "description": "Pharmacokinetic variables including area under the curve (AUC)",
                    "timeFrame": "Cycle 1 (at least 28 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including volume of distribution",
                    "description": "Pharmacokinetic variables including volume of distribution",
                    "timeFrame": "Cycle 1 (at least 28 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including clearance",
                    "description": "Pharmacokinetic variables including clearance",
                    "timeFrame": "Cycle 1 (at least 28 days)"
                },
                {
                    "measure": "Pharmacodynamic variables",
                    "description": "Determine PD variables by using a plasma inhibitory activity assay (PIA assay) examining the reduction in phospho-STAT5 and phospho-FLT3 in cell lines exposed to plasma from subjects treated in the study.",
                    "timeFrame": "4 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient is defined as having morphologically documented primary or secondary AML by the World Health Organization (WHO) criteria (2016) and fulfills one of the following:\n\n  1. Refractory to at least 1 cycle of prior therapy\n  2. Relapsed after achieving remission with a prior therapy\n* Patient has an Eastern Cooperative Oncology Group (ECOG) performance status \u2264 2.\n* Patient's interval from prior treatment to time of study drug administration is at least 2 weeks for cytotoxic agents (except hydroxyurea given for controlling blast cells), at 4 weeks for biologic or cellular immunotherapies, or at least 5 half-lives for prior experimental agents or noncytotoxic agents, including immunosuppressive therapy post hematopoietic stem cell transplantation (HSCT). (upon discussion with the Medical Monitor, shorter than stated washout period may be considered provided that the patient has recovered from any clinically relevant safety issue and recovered to Grade \u2264 1 toxicity from prior therapies)\n* Patient must meet the following criteria as indicated on the clinical laboratory tests\n\n  1. Serum aspartate aminotransferase(AST) and alanine aminotransferase(ALT) \u2264 2.5\u00d7 institutional upper limit normal (ULN)\n  2. Total serum bilirubin \u2264 1.5\u00d7 institutional ULN\n  3. Serum creatinine \u2264 1.5\u00d7 institutional ULN or an estimated glomerular filtration rate (eGFR) of \\> 45 ml/min as calculated by the Modification of Diet in Renal Disease (MDRD) equation.\n* Patient is suitable for oral administration of study drug and has minimum life expectancy (\u2265 3 months)\n* Female patient must be either:\n* Of non-child bearing potential\n\n  1. Post-menopausal (defined as at least 1 year without any menses) prior to screening, or\n  2. Documented surgically sterile or status post hysterectomy (at least 1 month prior to screening)\n* Or, if of childbearing potential,\n\n  1. Must have a negative serum or urine pregnancy test at screening (within 72 hours prior to start of treatment), and\n  2. Must use highly effective contraception starting at screening and throughout the study period and for 90 days after the final study drug administration.\n* Female patient must not be breastfeeding at screening and during the study period, and for 90 days after the final study drug administration\n* Female patient must not donate ova starting at screening and throughout the study period, and for 90 days after the final study drug administration.\n* Male patient and their female spouse/partners who are of childbearing potential must be using highly effective contraception starting at screening and continue throughout the study period and for 90 days after the final study drug administration.\n* Male patient must not donate sperm starting at screening and throughout the study period and for 90 days after the final study drug administration.\n* Patient agrees not to participate in another interventional study while on treatment\n\nExclusion Criteria:\n\nPatients must not enter the study if any of the following exclusion criteria are fulfilled.\n\n* Patient was diagnosed as acute promyelocytic leukemia (APL)\n* Patient has BCR-ABL-positive leukemia\n* Patient has an active malignancy other than AML, or Myelodysplastic Syndrome (MDS).\n* Patient has persistent non-hematological toxicities of \u2265 Grade 2 (CTCAE v4.03), with symptoms and objective findings, from prior AML treatment (including chemotherapy, kinase inhibitors, immunotherapy, experimental agents, radiation, or surgery)\n* Patient has had hematopoietic stem cell transplant (HSCT) and meets any of the following:\n\n  1. Has undergone HSCT within the 2 month period prior to the first study dose\n  2. Has clinically significant graft-versus-host-disease(GVHD) requiring treatment\n  3. Has \u2265 Grade 2 persistent non-hematological toxicity related to the transplant\n  4. Has a donor lymphocytes infusion (DLI) \u2264 30 days prior to the first study dose or during the first two cycle of treatment on the study.\n* Patient has meningeal or central nervous system (CNS) involvement with leukemia or other CNS disease related to underlying and secondary effects of malignancy.\n* Patient has disseminated intravascular coagulation abnormality (DIC).\n* Patient has had major surgery within 4 weeks prior to the first study dose.\n* Patient has had radiation therapy within 4 weeks prior to the first study dose.\n* Patient has congestive heart failure New York Heart Association (NYHA) class 3 or 4, or patient with a history of congestive heart failure NYHA class 3 or 4 in the past, unless a screening echocardiogram or multigated acquisition (MUGA) scan performed within 3 months prior to study entry results in a left ventricular ejection fraction (LVEF) that is \u2265 45%.\n* Any of the following cardiac abnormalities of history\n\n  1. Patient has any clinically important abnormalities in rhythm, conduction or morphology of resting ECG, e.g., complete left bundle branch block, third-degree heart block, second-degree heart block, or PR interval \\> 250 milliseconds (ms).\n  2. Patient has a mean QT interval (QTc) by Friderica's method (QTcF) \\> 450ms in three successive Screening measurements.\n  3. Patient has any factors that increase the risk of QTc prolongation or risk of arrhythmic events, such as congenital long QT, syndrome, family history of long QT syndrome.\n  4. Patient is unable or unwilling to discontinue concomitant use of drugs that are known to prolong the QT interval.\n* Patient is known to have active infection including any identified active COVID-19 infection.\n* Patient is known to have human immunodeficiency virus infection.\n* Patient has known active hepatitis B or C, or other active hepatic disorder.\n* Patient has any condition which, in the investigator's opinion, makes the patient unsuitable for study participation.\n* Patient has a history of Grade 3 or 4 non-hematologic toxicity related to tyrosine kinase inhibitor.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rafael Bejar, MD, PhD",
                    "role": "CONTACT",
                    "phone": "858-401-6852",
                    "email": "rbejar@aptose.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Naval Daver, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The Kirklin Clinic of UAB Hospital",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35233",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Pankit Vachhani, MD",
                            "role": "CONTACT",
                            "email": "jsregister@uabmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "City of Hope Comprehensive Cancer Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "University of California Irvine",
                    "status": "RECRUITING",
                    "city": "Irvine",
                    "state": "California",
                    "zip": "92697",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Deepa Jeyakumar, MD",
                            "role": "CONTACT",
                            "email": "djeyakum@hs.uci.edu"
                        },
                        {
                            "name": "Deepa Jeyakumar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.66946,
                        "lon": -117.82311
                    }
                },
                {
                    "facility": "UCSD Moores Cancer Center",
                    "status": "RECRUITING",
                    "city": "La Jolla",
                    "state": "California",
                    "zip": "92093",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carolyn Mulroney, MD",
                            "role": "CONTACT",
                            "email": "camulroney@health.ucsd.edu"
                        },
                        {
                            "name": "Carolyn Mulroney, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.84727,
                        "lon": -117.2742
                    }
                },
                {
                    "facility": "USC/Norris Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Eric Tam, MD",
                            "role": "CONTACT",
                            "email": "eric.tam@med.usc.edu"
                        },
                        {
                            "name": "Eric Tam, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Stanford Cancer Center",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gabriel Mannis, MD",
                            "role": "CONTACT",
                            "email": "gmannis@stanford.edu"
                        },
                        {
                            "name": "Gabriel Mannis, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                },
                {
                    "facility": "University of California, Davis",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brian Jonas",
                            "role": "CONTACT",
                            "phone": "916-703-9151",
                            "email": "bajonas@ucdavis.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                },
                {
                    "facility": "Yale University",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06520",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nikolai Podoltsev, MD",
                            "role": "CONTACT",
                            "email": "nikolai.podoltsev@yale.edu"
                        },
                        {
                            "name": "Nikolai Podoltsev, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "University of Miami - Miller School of Medicine",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Justin Watts, MD",
                            "role": "CONTACT",
                            "email": "jxw401@miami.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Emory University",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Martha Arellano",
                            "role": "CONTACT",
                            "phone": "404-712-0720",
                            "email": "marella@emory.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Amir Fathi, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Duke University Medical Center",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27705",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Harry Erba, MD",
                            "role": "CONTACT",
                            "email": "harry.erba@duke.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Cleveland Clinic - Taussig Cancer Center",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Studipto Mukherjee, MD",
                            "role": "CONTACT",
                            "email": "mukhers2@ccf.org"
                        },
                        {
                            "name": "Studipto Mukherjee, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "The Ohio State University Wexner Medical Center",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Uma Borate, MD",
                            "role": "CONTACT",
                            "email": "uma.borate@osumc.edu"
                        },
                        {
                            "name": "Uma Borate, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Naval Daver, Dr",
                            "role": "CONTACT",
                            "phone": "713-792-6477",
                            "email": "NDaver@mdanderson.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Border Medical Oncology",
                    "status": "RECRUITING",
                    "city": "Albury",
                    "state": "New South Wales",
                    "zip": "2640",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Anish Puliyayil, MD",
                            "role": "CONTACT",
                            "email": "apuliyayil@bordermedonc.com.au"
                        },
                        {
                            "name": "Anish Puliyayil, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -36.07482,
                        "lon": 146.92401
                    }
                },
                {
                    "facility": "Royal Brisbane and Women's Hospital",
                    "status": "RECRUITING",
                    "city": "Herston",
                    "state": "Queensland",
                    "zip": "4006",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Steven Lane, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Steven Lane, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -27.44453,
                        "lon": 153.01852
                    }
                },
                {
                    "facility": "Townsville University Hospital",
                    "status": "RECRUITING",
                    "city": "Townsville",
                    "state": "Queensland",
                    "zip": "4812",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Hock-Choong Lai, MD",
                            "role": "CONTACT",
                            "email": "Hock.lai@health.qld.gov.au"
                        },
                        {
                            "name": "Hock-Choong Lai, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -19.26639,
                        "lon": 146.80569
                    }
                },
                {
                    "facility": "St Vincent's Hospital Melbourne",
                    "status": "RECRUITING",
                    "city": "Fitzroy",
                    "state": "Victoria",
                    "zip": "3065",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Shuhying Tan, MD",
                            "role": "CONTACT",
                            "email": "ShuhYing.TAN@svha.org.au"
                        },
                        {
                            "name": "Shuhying Tan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -37.79839,
                        "lon": 144.97833
                    }
                },
                {
                    "facility": "Sir Charles Gairdner Hospital",
                    "status": "RECRUITING",
                    "city": "Nedlands",
                    "state": "Western Australia",
                    "zip": "6009",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Carolyn Grove, MD",
                            "role": "CONTACT",
                            "email": "carolyn.grove@health.wa.gov.au"
                        },
                        {
                            "name": "Carolyn Grove, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -31.98184,
                        "lon": 115.8073
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Leipzig",
                    "status": "RECRUITING",
                    "city": "Leipzig",
                    "state": "Saxony",
                    "zip": "04103",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Uwe Platzbecker, MD",
                            "role": "CONTACT",
                            "email": "uwe.platzbecker@medizin.uni-leipzig.de"
                        },
                        {
                            "name": "Uwe Platzbecker, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.33962,
                        "lon": 12.37129
                    }
                },
                {
                    "facility": "Charit\u00e9 Universit\u00e4tsmedizin Berlin",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "zip": "13353",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "J\u00f6rg Westermann, MD",
                            "role": "CONTACT",
                            "email": "joerg.westermann@charite.de"
                        },
                        {
                            "name": "J\u00f6rg Westermann, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "Kyungpook National University Hospital",
                    "status": "RECRUITING",
                    "city": "Daegu",
                    "zip": "41944",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Sang-Kyun Sohn",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.87028,
                        "lon": 128.59111
                    }
                },
                {
                    "facility": "Pusan National University Hospital",
                    "status": "RECRUITING",
                    "city": "Pusan",
                    "zip": "49241",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Ho-Jin Shin",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.10278,
                        "lon": 129.04028
                    }
                },
                {
                    "facility": "Seoul National University Bundang Hospital",
                    "status": "RECRUITING",
                    "city": "Seongnam",
                    "zip": "13620",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Jeong-Ok Lee",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.43861,
                        "lon": 127.13778
                    }
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Asan Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "05505",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Yunksuk Choi, MD",
                            "role": "CONTACT",
                            "phone": "+82-2-3010-3292",
                            "email": "choiysmd@gmail.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Chul-Won Jung",
                            "role": "CONTACT",
                            "phone": "+82-2-3410-2980",
                            "email": "chulwon1.jung@samsung.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Auckland City Hospital",
                    "status": "RECRUITING",
                    "city": "Grafton",
                    "state": "Auckland",
                    "zip": "1023",
                    "country": "New Zealand",
                    "contacts": [
                        {
                            "name": "Leanne Berkahn, MD",
                            "role": "CONTACT",
                            "email": "LeanneBerk@adhb.govt.nz"
                        },
                        {
                            "name": "Leanna Berkahn, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -36.86029,
                        "lon": 174.76566
                    }
                },
                {
                    "facility": "Hospital Universitario Central de Asturias",
                    "status": "RECRUITING",
                    "city": "Oviedo",
                    "state": "Asturias",
                    "zip": "33011",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Teresa Bernal",
                            "role": "CONTACT",
                            "email": "bernaldelcastillo@gmail.com"
                        },
                        {
                            "name": "Teresa Bernal",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.36029,
                        "lon": -5.84476
                    }
                },
                {
                    "facility": "Hospital Quir\u00f3n Madrid",
                    "status": "RECRUITING",
                    "city": "Pozuelo De Alarc\u00f3n",
                    "state": "Madrid",
                    "zip": "28223",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Carmen Martinez Chamorro, MD",
                            "role": "CONTACT",
                            "email": "carmen.chamorro@quironsalud.es"
                        },
                        {
                            "name": "Carmen Martinez Chammoro",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.43293,
                        "lon": -3.81338
                    }
                },
                {
                    "facility": "Hospital Universitario Vall d'Hebron",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Olga Salamero, MD",
                            "role": "CONTACT",
                            "email": "osalamero@vhio.net"
                        },
                        {
                            "name": "Olga Salamero",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Clinico Universitario de Valencia",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46010",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Maria Tormo, MD",
                            "role": "CONTACT",
                            "email": "tormo_mar@gva.es"
                        },
                        {
                            "name": "Maria Tormo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Hospital Universitari i Polit\u00e8cnic La Fe",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46026",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Pau Montesinos, MD",
                            "role": "CONTACT",
                            "email": "montesinos_pau@gva.es"
                        },
                        {
                            "name": "Pau Montesinos, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000007951",
                    "term": "Leukemia, Myeloid"
                },
                {
                    "id": "D000015470",
                    "term": "Leukemia, Myeloid, Acute"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10955",
                    "name": "Leukemia, Myeloid",
                    "asFound": "Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18127",
                    "name": "Leukemia, Myeloid, Acute",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3995",
                    "name": "Myeloid Leukemia",
                    "asFound": "Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T182",
                    "name": "Acute Myeloid Leukemia",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T188",
                    "name": "Acute Non Lymphoblastic Leukemia",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000579720",
                    "term": "Venetoclax"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M249656",
                    "name": "Venetoclax",
                    "asFound": "0.1",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}